Press Release Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026 22 February 2026
Press Release Dassault Systèmes’ CEO Pascal Daloz Becomes Also Chairman of the Board of Directors of Dassault Systèmes 21 February 2026
Press Release INVESTOR NOTICE: Kyndryl Holdings, Inc. (KD) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces 21 February 2026
Press Release INVESTOR NOTICE: PayPal Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces 21 February 2026
Press Release INVESTOR DEADLINE: NuScale Power Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit Filed by Robbins Geller Rudman & Dowd LLP 21 February 2026
Press Release INVESTOR NOTICE: Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces 21 February 2026
Press Release The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders 21 February 2026
Press Release Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated 21 February 2026
Press Release Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit 21 February 2026
Press Release REMINDER: Beyond Meat, Inc. Investors With Significant Losses Must Act By March 24, 2026 21 February 2026
